clinical trial Archive — Page 6 of 16

A traditionally dressed woman kneels on a patterned floor beside a mat holding shells, dice, and other divination objects, reaching toward them while a wooden stick lies nearby.
April 25, 2024

Traditional healer-initiated HIV testing and care expands in South Africa

Developed in a region with the world’s highest HIV prevalence, this study design and intervention has the potential to impact testing uptake among a “hidden population” by mobilizing trained healers, who vastly outnumber allopathic care providers in South Africa.

Stylized blue human torso beside a glowing green electrocardiogram waveform on a dark grid background.
April 25, 2024

Advance in the treatment of acute heart failure identified

A multicenter study led by Vanderbilt University Medical Center and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death.

Illustration of clinicians and biostatisticians working collaboratively on research
April 16, 2024

Unsung Zeros: How biostatistics advances personalized health in the era of smart data

VUMC is acrawl with statistical design, bias detection and analysis that’s recognized with $532 million in federal and nonfederal research support.

Close-up of a lit cigarette with glowing ash and smoke rising against a black background.
February 29, 2024

Study targets nicotine craving in schizophrenia

Vanderbilt’s Heather Burrell Ward, MD, has received a five-year, $928,000 grant from the National Institute on Drug Abuse to test whether an externally applied magnetic field can reduce nicotine craving in people with schizophrenia.

White disposable surgical mask labeled “COVID-19” on a light blue background.
February 22, 2024

NIH-funded trial to determine if immunomodulation can improve brain and cardiovascular dysfunction in Long COVID

Vanderbilt University Medical Center is working with scientists around the U.S. to launch the first Phase III, multicenter, placebo-controlled trial to determine the effect of immunomodulation on Long COVID.

Five adults pose together in a hospital corridor. A man in medical scrubs stands at left, with two men and two women beside him; the central man wears a striped shirt and jeans.
February 20, 2024

System offers new option to treat mitral regurgitation

In a novel procedure, the Vanderbilt Heart & Vascular Institute (VHVI) successfully performed the first large-flange Innovalve transcatheter mitral valve replacement.